Project duration: 3 Years
Project's focus area: Reducing maternal mortality after home births beyond reach of clinics and government health services
|
|
|
|
Each year, twice as many women die in childbirth as people who died in the 2004 tsunami. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but our projects are the first to show traditional midwives can save lives in a woman’s home, where most births take place. This is also where most maternal deaths occur in the developing world--well beyond the reach of hospitals and government health services.
|
|
|
|
We sponsor clinical demonstration studies with traditional midwives; co-sponsor government policy meetings; train doctors and midwives to use misoprostol; and develop market distribution for the drug to be available in pharmacies & clinics countrwide |
|
|
|
The project is uniquely scalable and sustainable. With this drug, traditional midwives get their first effective technology and see the first large-scale decline in mortality. Low-cost distribution will ensure widespread access. |
|
|
“My eldest daughter died of postpartum hemorrhage four years ago. In this project we are saving women’s lives with misoprostol. If we had had this earlier, we would have saved her life too.”
- Margaum, traditional midwife in our Tanzanian study
|
Amy Grossman,
Project contact
Venture Strategies
2140 Shattuck Avenue, Suite 1110
Berkeley, California 94704-1234
United States
510-665-1880
|
|
|
|
|
